The major vendors ratcheted things up a notch in the radiography and fluoroscopy (R/F) arena, focusing on total interventional solutions and specific enhancements, including improved dose control, during the 2004 RSNA scientific meeting.
The major vendors ratcheted things up a notch in the radiography and fluoroscopy (R/F) arena, focusing on total interventional solutions and specific enhancements, including improved dose control, during the 2004 RSNA scientific meeting.
GE Healthcare launched its Interventional Suite, featuring the OEC 9800 MD digital motorized mobile imaging system. The system includes ceiling-supported monitors, four-way floating imaging tables, and contrast injectors.
Siemens Medical Solutions received 510(k) clearance for DynaCT, an enhancement for its C-arm angiography systems that allows soft-tissue imaging. The upgrade is touted as the first application that enables angiographic CT.
On the general-purpose R/F side, Philips' EasyDiagnost Eleva was shown with CR integration, enabling customers to fully digitize their R/F suites.
GE Healthcare provides medical technologies designed to improve patient care, with expertise in medical imaging and information technologies, medical diagnostics, and patient monitoring systems to detect disease early and tailor treatment to individual patients.
The company has a 20-year history of developing digital medical imaging solutions. This year, Infimed introduced a new series of cardiology products based on its PlatinumOne in-room digital acquisition platform designed to support complex interventional procedures.
Philips competes with GE and Siemens for market leadership in various areas of medical diagnostic imaging.
Siemens is an imaging leader with a reputation for consistency. Its solutions range from imaging systems and therapy equipment to electromedical and instruments.
Thales designs and manufactures CCD cameras for radiological applications.
Toshiba markets, sells, distributes, and services diagnostic imaging systems, while coordinating clinical diagnostic imaging research for all modalities in the U.S. The company is a global provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, x-ray, ultrasound, nuclear medicine, and MRI systems.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.